Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.

AI/ML

Biotechnology

Health Care

Software

Oncoustics AI

Beth Rogozinski

Miriam Naim Ibrahim

Raúl Blázquez García

Shahid Rashid

Ahmed E.

The Clinical and Data Operations team at Oncoustics AI is responsible for managing and optimizing the collection, processing, and analysis of clinical data related to advanced AI solutions for disease diagnostics and monitoring. This team collaborates closely with healthcare providers to gather high-quality raw ultrasound signals, ensuring data integrity, regulatory compliance, and effective utilization for AI model training. They work on clinical trials, data management, and the integration of novel biomarkers to improve diagnostic accuracy and support the deployment of Oncoustics' innovative technology in the medical field.

Clinical and Data Operations

Engineering and Development

Clinical and Data Operations

About

Team members

Other teams at Oncoustics AI

Engineering and Development